D-Dimer Quantitative Test Kit: Procurement and Workflow Checks

D-Dimer Quantitative Test Kit (Quantum Dot Fluorescence Immunochromatography)

Laboratories evaluating a D-dimer assay often begin with sample type, throughput, and existing instrument support rather than the biomarker name alone. The supplied listing identifies product code GKPD056, a 25 T/box configuration, and a fluorescence immunochromatography method.

The stated function is quantitative detection of D-dimer concentration in human whole blood and plasma using a double-antibody sandwich method. That establishes the analytical target and the sample matrices the kit is intended to handle.

Fluorescence immunochromatography normally depends on a compatible fluorescence reader, but the input does not name one. A buyer should verify reader requirements, calibration, and control materials before assuming the kit drops into an existing bench setup.

The listing places the kit in a Testing for Myocardial Markers portfolio. That is a catalog grouping, not a confirmed clinical indication. Procurement teams should request intended-use documentation, regulatory status for the target market, and language requirements.

Pack size affects storage, shelf-life, and reorder cadence. Availability, MOQ, lead time, shipping, configuration, and quotation are not fixed in the input and should be confirmed directly with the supplier.

A D-dimer kit is one component of a testing system. Sample type, reader compatibility, controls, and documentation usually determine whether it fits an operational workflow.

Why it matters:
For buyers, the decisive questions are sample type, reader requirements, regulatory documents, and pack economics—not the biomarker name alone.

View Product →